These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 24676447)

  • 1. H7N9 bird flu: emerging of psychological problem.
    Joob B; Wiwanitkit V
    Arq Neuropsiquiatr; 2014 Mar; 72(3):257. PubMed ID: 24676447
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuropsychiatric problems due to oseltamivir treatment in H7N9 bird flu.
    Wiwanitkit V
    Arq Neuropsiquiatr; 2014 Feb; 72(2):172. PubMed ID: 24604374
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical efficacy observation of atomization inhalation combined with oral administration of oseltamivir in 4 cases with H7N9 avian influenza].
    Li Z; Fu XY; Fang XB; Li J; Chen T; Qiu LM; Cai J; Wang WL; Pan ZQ; Zhang Y; Zhou JL
    Zhonghua Yi Xue Za Zhi; 2017 Jun; 97(24):1883-1887. PubMed ID: 28648014
    [No Abstract]   [Full Text] [Related]  

  • 4. A/H1N1 flu. Time for case-control studies of NSAIDs and oseltamivir.
    Herxheimer A; Clarke M; Edwards R; Jefferson T; Loke Y
    BMJ; 2009 Jul; 339():b3048. PubMed ID: 19638383
    [No Abstract]   [Full Text] [Related]  

  • 5. Preliminary Epidemiology of Human Infections with Highly Pathogenic Avian Influenza A(H7N9) Virus, China, 2017.
    Zhou L; Tan Y; Kang M; Liu F; Ren R; Wang Y; Chen T; Yang Y; Li C; Wu J; Zhang H; Li D; Greene CM; Zhou S; Iuliano AD; Havers F; Ni D; Wang D; Feng Z; Uyeki TM; Li Q
    Emerg Infect Dis; 2017 Aug; 23(8):1355-1359. PubMed ID: 28580900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human infection with a novel H7N9 avian influenza virus in Yunnan, China.
    Feng Y; Gao L; Miao J; Zhang M; Zhang C; Wang X; Zhao Y; Zhao J; Min H; Dong X; Xia X
    J Infect; 2018 Jan; 76(1):98-101. PubMed ID: 28797725
    [No Abstract]   [Full Text] [Related]  

  • 7. Discovery process, clinical characteristics, and treatment of patients infected with avian influenza virus (H7N9) in Shanghai.
    Sun Y; Shen Y; Lu H
    Chin Med J (Engl); 2014; 127(1):185-6. PubMed ID: 24384446
    [No Abstract]   [Full Text] [Related]  

  • 8. Using oseltamivir (Tamiflu) as a first line treatment for seasonal or pandemic flu.
    Greener M
    Nurs Times; 2009 Sep 1-7; 105(34):22. PubMed ID: 19788111
    [No Abstract]   [Full Text] [Related]  

  • 9. Adolescent jump case in Japan associated with influenza but not oseltamivir.
    Terada K; Kawai Y; Monju A; Wakabayashi T; Ouchi K
    Pediatr Infect Dis J; 2008 Jan; 27(1):88-9. PubMed ID: 18162953
    [No Abstract]   [Full Text] [Related]  

  • 10. Discovery of potential drugs for human-infecting H7N9 virus containing R294K mutation.
    He JY; Li C; Wu G
    Drug Des Devel Ther; 2014; 8():2377-90. PubMed ID: 25489236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuraminidase Mutations Conferring Resistance to Oseltamivir in Influenza A(H7N9) Viruses.
    Marjuki H; Mishin VP; Chesnokov AP; De La Cruz JA; Davis CT; Villanueva JM; Fry AM; Gubareva LV
    J Virol; 2015 May; 89(10):5419-26. PubMed ID: 25740997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of human influenza A(H7N9) infection in Hong Kong.
    Leung YH; To MK; Lam TS; Yau SW; Leung OS; Chuang SK
    J Microbiol Immunol Infect; 2017 Apr; 50(2):183-188. PubMed ID: 26220305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of novel reassortant avian influenza H7N9 virus infection in vitro with three antiviral drugs, oseltamivir, peramivir and favipiravir.
    Cao RY; Xiao JH; Cao B; Li S; Kumaki Y; Zhong W
    Antivir Chem Chemother; 2014 Dec; 23(6):237-40. PubMed ID: 23948557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy of H7N9 pneumonia: current perspectives.
    Cao B; Hayden FG
    Expert Rev Anti Infect Ther; 2013 Nov; 11(11):1123-6. PubMed ID: 24151830
    [No Abstract]   [Full Text] [Related]  

  • 15. Oseltamivir-induced mania in a patient with H1N1.
    Ho LN; Chung JP; Choy KL
    Am J Psychiatry; 2010 Mar; 167(3):350. PubMed ID: 20194491
    [No Abstract]   [Full Text] [Related]  

  • 16. Tamiflu: what dermatologists need to know.
    Bergstrom KG
    J Drugs Dermatol; 2010 Jan; 9(1):76-8. PubMed ID: 20120431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of H7N9 Influenza A Virus Resistant to Neuraminidase Inhibitors in Nonhuman Primates.
    Itoh Y; Shichinohe S; Nakayama M; Igarashi M; Ishii A; Ishigaki H; Ishida H; Kitagawa N; Sasamura T; Shiohara M; Doi M; Tsuchiya H; Nakamura S; Okamatsu M; Sakoda Y; Kida H; Ogasawara K
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4962-73. PubMed ID: 26055368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergence of a novel drug resistant H7N9 influenza virus: evidence based clinical potential of a natural IFN-α for infection control and treatment.
    Liu Q; Ma J; Strayer DR; Mitchell WM; Carter WA; Ma W; Richt JA
    Expert Rev Anti Infect Ther; 2014 Feb; 12(2):165-9. PubMed ID: 24350808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oseltamivir treatment for influenza does not increase digestive intolerance in preterm infants.
    Leick-Courtois C; Haÿs S; Basson E; Mory-Thomas N; Boibieux A; Picaud JC
    Acta Paediatr; 2014 Mar; 103(3):e136-7. PubMed ID: 24372794
    [No Abstract]   [Full Text] [Related]  

  • 20. Viral genome and antiviral drug sensitivity analysis of two patients from a family cluster caused by the influenza A(H7N9) virus in Zhejiang, China, 2013.
    Gao HN; Yao HP; Liang WF; Wu XX; Wu HB; Wu NP; Yang SG; Zhang Q; Su KK; Guo J; Zheng SF; Zhu YX; Chen HL; Yuen KY; Li LJ
    Int J Infect Dis; 2014 Dec; 29():254-8. PubMed ID: 25462187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.